Augurex and Quidel are pleased to announce the launch of the JOINTstat® 14-3-3η RUO (research use only) ELISA. This new distribution arrangement will get 14-3-3η testing into the hands of… read more →
At the annual European congress of rheumatology meeting, The European League Against Rheumatism (EULAR), taking place in Amsterdam on June 13th-16th, leading investigators from United States, Israel, and Egypt will… read more →
Did you miss the Digital Technology Supercluster Member Spotlight on Augurex? Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory… read more →
Working in STEM means that you’re innovative, you’re creative, you’re passionate, you’re clever, you’re whoever you want to be. We’re so proud of our CEO Norma Biln being recognized by BC… read more →
Honored to be recognized by “Ready to Rocket” as one of the 10 featured Life Sciences companies to experience accelerated growth. We’re excited for the future! About Ready to Rocket:… read more →
In a study of over 800 rheumatoid arthritis (RA) patients, presented this week at the Canadian Rheumatology (CRA) Association Meeting, it was shown that a positive 14-3-3η blood test amplified… read more →
As a founding member, we are thrilled that the BC-led #DigitalSupercluster has been chosen. Truly an exciting day for technology innovation in Canada! Read full story
Augurex CEO Norma Biln was awarded Canada’s Most Powerful Women: Top 100 Award for her extraordinary leadership and continued drive to inspire others. The Top 100 Award Winner community now… read more →